Volume 14 Issue 1
Jan.  2023
Turn off MathJax
Article Contents
ZHOU Runing, ZHANG Li, MA Kaiyu, BAO Xiuqi, WANG Weiguo, RUAN Gechong, YANG Hong. Investigation and Risk Factors of Helicobacter pylori Infection in Patients with Inflammatory Bowel Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 124-130. doi: 10.12290/xhyxzz.2022-0639
Citation: ZHOU Runing, ZHANG Li, MA Kaiyu, BAO Xiuqi, WANG Weiguo, RUAN Gechong, YANG Hong. Investigation and Risk Factors of Helicobacter pylori Infection in Patients with Inflammatory Bowel Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 124-130. doi: 10.12290/xhyxzz.2022-0639

Investigation and Risk Factors of Helicobacter pylori Infection in Patients with Inflammatory Bowel Disease

doi: 10.12290/xhyxzz.2022-0639
Funds:

National Key Clinical Specialty Construction Project ZK108000

CAMS Innovation Fund for Medical Sciences 2022-I2M-C&T-B-011

National High-level Hospital Clinical Research Funding 2022-PUMCH-C-018

More Information
  • Corresponding author: RUAN Gechong, E-mail: ruangechong@pumch.cn
  • Received Date: 2022-11-09
  • Accepted Date: 2022-12-06
  • Publish Date: 2023-01-30
  •   Objective  To investigate the rate and risk factors of Helicobacter pylori(Hp) infection in patients with inflammatory bowel disease(IBD).  Methods  A survey was conducted from January 1, 2020 to December 31, 2020 by sending an electronic questionnaire to long-term follow-up IBD patients of Peking Union Medical College Hospital and age-sex-matched Beijing community residents. General information, information related to Hp infection and environmental factors were collected from the two groups. The differences in Hp positivity rates between the two groups and IBD patients with different clinical profiles were compared.  Results  After propensity score matching, 122 patients with IBD and 1739 community residents were finally included in this study. The histograms of propensity score values were highly consistent between the two groups. The ratio of Hp infection was significantly lower in IBD patients than in the community residents (13.1% vs. 42.7%, P < 0.001). The ratio of Hp infection in both groups increased with age but showed no statistical significance (all P > 0.05). Univariate analysis showed that the IBD patients with Hp positive co-diners had a significantly higher ratio of Hp infection than those with Hp negative co-diners (43.8% vs. 18.9%, P=0.006).  Conclusions  The Hp infection rate was lower in IBD patients than in community residents. The possible risk factor may be co-dining with Hp positives.
  • loading
  • [1] Yang H, Zhou R, Bai X, et al. Trend and Geographic Variation in Incidence and Prevalence of Inflammatory Bowel Disease in Regions Across China: A Nationwide Employee Study Between 2013 and 2016[J]. Front Med (Lausanne), 2022, 9: 900251.
    [2] Chang JT. Pathophysiology of Inflammatory Bowel Diseases[J]. N Engl J Med, 2020, 383: 2652-2664. doi:  10.1056/NEJMra2002697
    [3] Piovani D, Danese S, Peyrin-Biroulet L, et al. Environ-mental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses[J]. Gastroenterology, 2019, 157: 647-659 e4. doi:  10.1053/j.gastro.2019.04.016
    [4] Ren S, Cai P, Liu Y, et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2022, 37: 464-470. doi:  10.1111/jgh.15751
    [5] Wu XW, Ji HZ, Yang MF, et al. Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis[J]. World J Gastroenterol, 2015, 21: 4750-4756. doi:  10.3748/wjg.v21.i15.4750
    [6] Yu Y, Zhu S, Li P, et al. Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract[J]. Cell Death Dis, 2018, 9: 961. doi:  10.1038/s41419-018-0982-2
    [7] Kienesberger S, Cox LM, Livanos A, et al. Gastric Helicobacter pylori Infection Affects Local and Distant Microbial Populations and Host Responses[J]. Cell Rep, 2016, 14: 1395-1407. doi:  10.1016/j.celrep.2016.01.017
    [8] Luther J, Owyang SY, Takeuchi T, et al. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis[J]. Gut, 2011, 60: 1479-1486. doi:  10.1136/gut.2010.220087
    [9] 吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志, 2018, 38: 796-813. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201809007.htm
    [10] 国家消化系疾病临床医学研究中心, 中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组, 全国幽门螺杆菌研究协作组. 中国居民家庭幽门螺杆菌感染的防控和管理专家共识(2021年)[J]. 中华消化杂志, 2021, 41: 221-233. doi:  10.3760/cma.j.cn311367-20210219-00108
    [11] 国家技术监督局. GB3869-1997《体力劳动强度分级》[EB/OL]. (1997-07-07)[2022-11-09]. https://max.book118.com/html/2018/1224/5324311100001342.shtm.
    [12] el-Omar E, Penman I, Cruikshank G, et al. Low preval-ence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine[J]. Gut, 1994, 35: 1385-1388. doi:  10.1136/gut.35.10.1385
    [13] Ding ZH, Xu XP, Wang TR, et al. The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study[J]. PLoS One, 2021, 16: e0248427. doi:  10.1371/journal.pone.0248427
    [14] Castano-Rodriguez N, Kaakoush NO, Lee WS, et al. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis[J]. Gut, 2017, 66: 235-249. doi:  10.1136/gutjnl-2015-310545
    [15] Song MJ, Park DI, Hwang SJ, et al. The prevalence of Helicobacter pylori infection in Korean patients with inflam-matory bowel disease, a multicenter study[J]. Korean J Gastroenterol, 2009, 53: 341-347. doi:  10.4166/kjg.2009.53.6.341
    [16] Abd El-Wahab EW, Youssef EI, Hassouna E. Helicobacter pylori infection in patients with inflammatory bowel diseases: a single-centre, prospective, observational study in Egypt[J]. BMJ Open, 2022, 12: e057214. doi:  10.1136/bmjopen-2021-057214
    [17] Bartels LE, Jepsen P, Christensen LA, et al. Diagnosis of Helicobacter Pylori Infection is Associated with Lower Prevalence and Subsequent Incidence of Crohn's Disease[J]. J Crohns Colitis, 2016, 10: 443-448. doi:  10.1093/ecco-jcc/jjv229
    [18] Lin KD, Chiu GF, Waljee AK, et al. Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases[J]. Clin Gastroenterol Hepatol, 2019, 17: 1991-1999. doi:  10.1016/j.cgh.2018.12.014
    [19] Zhong Y, Zhang Z, Lin Y, et al. The Relationship Between Helicobacter pylori and Inflammatory Bowel Disease[J]. Arch Iran Med, 2021, 24: 317-325. doi:  10.34172/aim.2021.44
    [20] Li X, Tan J, Zhang F, et al. H. pylori Infection Alleviates Acute and Chronic Colitis with the Expansion of Regulatory B Cells in Mice[J]. Inflammation, 2019, 42: 1611-1621. doi:  10.1007/s10753-019-01022-0
    [21] Zhang H, Dai Y, Liu Y, et al. Helicobacter pylori Colonization Protects Against Chronic Experimental Colitis by Regulating Th17/Treg Balance[J]. Inflamm Bowel Dis, 2018, 24: 1481-1492.
    [22] Yang F, Xu YL, Zhu RF. Helicobacter pylori infection and the risk of colorectal carcinoma: a systematic review and meta-analysis[J]. Minerva Med, 2019. 110: 464-470.
    [23] Bai X, Jiang L, Ruan G, et al. Helicobacter pylori may participate in the development of inflammatory bowel disease by modulating the intestinal microbiota[J]. Chin Med J (Engl), 2022, 135: 634-638.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(2)

    Article Metrics

    Article views (2563) PDF downloads(69) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return